Drug profile · INN
sitagliptin
JANUVIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sitagliptin (JANUVIA) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: film coated. Current US regulatory status: approved.
Key facts
INN sitagliptin
Brand JANUVIA
Route FILM COATED
Formulation TABLET
ATC code A10BH01
Originator Alphapharm Pty Ltd
Frequently asked questions
What is sitagliptin?
sitagliptin (JANUVIA) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: film coated. Current US regulatory status: approved.
What is the brand name for sitagliptin?
JANUVIA is a marketed brand name for sitagliptin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sitagliptin?
sitagliptin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.